tanshinone has been researched along with Liver Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, Y; Gong, J; Li, X; Wu, Y; Zhang, W | 1 |
Dong, BS; Shi, MJ; Su, SB; Yang, WN; Zhang, H | 1 |
Hiroshi, K; Jiang, T; Xu, JK; Yao, XS; Zheng, JJ | 1 |
1 review(s) available for tanshinone and Liver Diseases
Article | Year |
---|---|
Preventive and therapeutic role of Tanshinone ⅡA in hepatology.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Humans; Liver Diseases; Liver Neoplasms; Plant Extracts | 2019 |
2 other study(ies) available for tanshinone and Liver Diseases
Article | Year |
---|---|
Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells.
Topics: Abietanes; Animals; HMGB1 Protein; Interleukin-10; Interleukin-4; Kupffer Cells; Liver; Liver Diseases; Liver Transplantation; Male; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Transcription Factor RelA; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |
[Protective effect of tanshinones against liver injury in mice loaded with restraint stress].
Topics: Abietanes; Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Drugs, Chinese Herbal; Glutathione; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Phenanthrenes; Plants, Medicinal; Protective Agents; Reactive Oxygen Species; Restraint, Physical; Salvia miltiorrhiza; Stress, Physiological | 2006 |